MedTrace Logo

Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid In Hands Rejuvenation

NCT01774396 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-02-26

No results posted yet for this study

Summary

Assessment of efficacy of hyaluronic acid - Emervel® Volume Lidocaine combined or not with Emervel® Touch and Emervel® Deep Lidocaine combined or not with Emervel® Touch in female patients with loss of fatty tissue in hands.

Conditions

  • Injuries to the Wrist and Hand

Interventions

DRUG

Emervel® Touch

Emervel® Touch will be injected only in the intervention group.

DRUG

Emervel® Volume Lidocaine and Emervel® Deep Lidocaine

Emervel® Volume Lidocaine and Emervel® Deep Lidocaine will be injected in the group #2.

Sponsors & Collaborators

  • Brazilan Center for Studies in Dermatology

    lead OTHER

Principal Investigators

  • Doris Hexsel, MD · BRAZILIAN CENTER FOR STUDIES IN DERMATOLOGY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01774396 on ClinicalTrials.gov